SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-215418
Filing Date
2021-07-14
Accepted
2021-07-14 17:21:32
Documents
14
Period of Report
2021-07-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d194905d8k.htm   iXBRL 8-K 27444
2 EX-99.1 d194905dex991.htm EX-99.1 12402
6 GRAPHIC g194905g0715015945582.jpg GRAPHIC 2076
  Complete submission text file 0001193125-21-215418.txt   171204

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fstx-20210708.xsd EX-101.SCH 2909
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20210708_lab.xml EX-101.LAB 18054
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20210708_pre.xml EX-101.PRE 11392
7 EXTRACTED XBRL INSTANCE DOCUMENT d194905d8k_htm.xml XML 3397
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 211090938
SIC: 2834 Pharmaceutical Preparations